Attana inks microsampling collaboration with Capitainer for improved diagnostic sampling

Combining Attana’s advanced biosensor system with Capitainer’s DBS home sampling makes immune profiling and vaccine efficacy monitoring possible in broad patient populations.Swedish bio- and healthtech companies Attana AB and Capitainer AB have signed an agreement with the goal of offering broader and more patient-centric blood sampling solutions for the Attana AVA[TM] system starting with COVID-19 immune profiling. Since November 2021, Attana has been performing comparative studies of finger stick capillary blood samples simultaneously collected by both test tubes and Capitainer®qDBS